Spruce Biosciences, Inc. Common Stock (SPRB) — Long-term Investment Intensity

Latest as of June 2022: 5.6%

Spruce Biosciences, Inc. Common Stock (SPRB) has a Long-term Investment Intensity of 5.6% as of June 2022. Long-term investments of $5.80 Million represent 5.6% of total assets of $104.52 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See SPRB net asset value for net asset value and shareholders' equity analysis.

LT Investment Intensity

5.6%
LT Investments / Total Assets

Long-term Investments

$5.80 Million
USD

Total Assets

$104.52 Million
USD

Country

USA
NASDAQ

Spruce Biosciences, Inc. Common Stock Long-term Investment Intensity (2021–2021)

This chart shows how Spruce Biosciences, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2021 to 2021. As of June 2022, the intensity stands at 5.6%, reflecting long-term investments of $5.80 Million against total assets of $104.52 Million USD. Also explore Spruce Biosciences, Inc. Common Stock (SPRB) total assets for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Spruce Biosciences, Inc. Common Stock (2021–2021)

The table below presents the year-by-year Long-term Investment Intensity for Spruce Biosciences, Inc. Common Stock from 2021 to 2021, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Spruce Biosciences, Inc. Common Stock worth.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2021 25.7% $32.46 Million $126.49 Million
pp = percentage points